IL162182A0 - Kits containing oral contraceptives and methods utilizing the same - Google Patents

Kits containing oral contraceptives and methods utilizing the same

Info

Publication number
IL162182A0
IL162182A0 IL16218202A IL16218202A IL162182A0 IL 162182 A0 IL162182 A0 IL 162182A0 IL 16218202 A IL16218202 A IL 16218202A IL 16218202 A IL16218202 A IL 16218202A IL 162182 A0 IL162182 A0 IL 162182A0
Authority
IL
Israel
Prior art keywords
same
methods utilizing
kits containing
oral contraceptives
containing oral
Prior art date
Application number
IL16218202A
Other languages
English (en)
Original Assignee
Barr Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23313290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL162182(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Barr Lab Inc filed Critical Barr Lab Inc
Publication of IL162182A0 publication Critical patent/IL162182A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16218202A 2001-12-05 2002-12-04 Kits containing oral contraceptives and methods utilizing the same IL162182A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33580701P 2001-12-05 2001-12-05
PCT/US2002/038602 WO2003049744A1 (en) 2001-12-05 2002-12-04 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Publications (1)

Publication Number Publication Date
IL162182A0 true IL162182A0 (en) 2005-11-20

Family

ID=23313290

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16218202A IL162182A0 (en) 2001-12-05 2002-12-04 Kits containing oral contraceptives and methods utilizing the same
IL162182A IL162182A (en) 2001-12-05 2004-05-27 Kits containing oral contraceptives and methods utilizing the same
IL207561A IL207561A0 (en) 2001-12-05 2010-08-12 Kits containing oral contraceptives and methods utilizing the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL162182A IL162182A (en) 2001-12-05 2004-05-27 Kits containing oral contraceptives and methods utilizing the same
IL207561A IL207561A0 (en) 2001-12-05 2010-08-12 Kits containing oral contraceptives and methods utilizing the same

Country Status (22)

Country Link
US (5) US7320969B2 (enExample)
EP (3) EP2305229A1 (enExample)
JP (3) JP2005516913A (enExample)
CN (2) CN100581550C (enExample)
AU (2) AU2002348272B2 (enExample)
BG (1) BG108736A (enExample)
BR (1) BRPI0214716B8 (enExample)
CA (2) CA2468748C (enExample)
DK (1) DK1453521T3 (enExample)
ES (2) ES2561491T3 (enExample)
FR (1) FR15C0050I2 (enExample)
HU (2) HU230759B1 (enExample)
IL (3) IL162182A0 (enExample)
LU (1) LU93156I2 (enExample)
MX (1) MXPA04005445A (enExample)
NZ (4) NZ570295A (enExample)
PL (1) PL213122B1 (enExample)
PT (1) PT1453521E (enExample)
RU (1) RU2351339C2 (enExample)
SI (1) SI1453521T1 (enExample)
WO (1) WO2003049744A1 (enExample)
ZA (1) ZA200404249B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
MXPA04005445A (es) 2001-12-05 2005-03-23 Barr Lab Inc Anticonceptivos orales para prevenir el embarazo y disminuir la sintomatologia premenstrual.
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
JP2006525358A (ja) * 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
US20090163454A1 (en) * 2003-05-02 2009-06-25 Duramed Pharmaceuticals, Inc. Methods of Step-Down Hormone Treatment
US20040222123A1 (en) * 2003-05-06 2004-11-11 Barr Laboratories, Inc. Kit for pharmaceuticals
NZ585546A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
ATE474795T1 (de) 2003-09-04 2010-08-15 Pharmadesign Inc Behälter mit tablettenaufnahmehülsen zur lagerung und ausgabe von tabletten
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
EP1735056B1 (en) 2004-03-19 2012-10-24 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
US20050250746A1 (en) * 2004-05-06 2005-11-10 Matthew Iammatteo Premenstrual dysphoric disorder medication
EP1755618A1 (en) * 2004-05-26 2007-02-28 Wyeth a Corporation of the State of Delaware Compositions and methods for treatment of premenstrual dysphoric disorder
WO2006036055A2 (en) * 2004-09-27 2006-04-06 Pantarhei Bioscience B. V. Method of female contraception and kit for use in such method
MX2007004120A (es) * 2004-10-07 2007-06-15 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20060241092A1 (en) * 2005-04-15 2006-10-26 Anderson Freedolph D Contraceptive regimens for lower-weight women
TW200726473A (en) * 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
DE102005056527A1 (de) * 2005-11-25 2007-07-12 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
US9517328B2 (en) 2013-06-19 2016-12-13 Kashiv Pharma, Llc Medicament applicator
ES2950096T3 (es) 2016-09-22 2023-10-05 Alan B Cash Método para aliviar los síntomas del síndrome premenstrual
US11679114B2 (en) * 2021-07-26 2023-06-20 Navad Life Sciences Pte Progestogen-only oral contraception

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428051A (en) * 1890-05-13 Wood-working machine
US575690A (en) * 1897-01-26 Match-safe
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US4171358A (en) 1974-04-19 1979-10-16 Eli Lilly And Company Novel contraceptive method
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4291014A (en) 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
USRE35724E (en) * 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4736849A (en) 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4534468A (en) 1983-12-19 1985-08-13 Nuckols Walter S Calendar-oriented pill dispenser
JPS60174716A (ja) 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4962098A (en) 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
US5010070A (en) 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US4971998A (en) * 1987-10-22 1990-11-20 Massachusetts Institute Of Technology Methods for treating the premenstrual or late luteal phase syndrome
ATE175358T1 (de) * 1987-10-22 1999-01-15 Massachusetts Inst Technology Behandlung des prämenstruellen oder späten lutealsphase-syndroms
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
US5098714A (en) 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
ATE115123T1 (de) * 1990-10-25 1994-12-15 Schering Corp Verfahren zur herstellung von florfenicol, seine analoga und oxazolinzwischenprodukte.
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (enExample) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19531936A1 (de) 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6139873A (en) 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
WO1998004267A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
ES2229378T3 (es) * 1996-07-26 2005-04-16 Wyeth Anticonceptivo oral.
AU3961697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
AU3888597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
AU4043597A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) * 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
DE19705229C2 (de) * 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
WO1998042671A1 (de) * 1997-03-20 1998-10-01 Basf Aktiengesellschaft Substituierte 2-benz(o)ylpyridin derivate, deren herstellung und deren verwendung als herbizide
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6251956B1 (en) * 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
MXPA03000170A (es) 2000-07-06 2003-05-27 Wyeth Corp Combinaciones de un inhibidor de recaptacion de serotonina selectivo y agentes estrogenicos.
CA2446849A1 (en) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
US20030018018A1 (en) * 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
MXPA04005445A (es) 2001-12-05 2005-03-23 Barr Lab Inc Anticonceptivos orales para prevenir el embarazo y disminuir la sintomatologia premenstrual.
ES2197801B1 (es) * 2002-03-05 2005-03-16 Ferrer Internacional,S.A Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
US20030229057A1 (en) * 2002-03-11 2003-12-11 Caubel Patrick Michel Continuous sulfatase inhibiting progestogen hormone replacement therapy
US20030219471A1 (en) 2002-03-11 2003-11-27 Caubel Patrick Michel Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
US20040142914A1 (en) * 2002-03-11 2004-07-22 Friedman Andrew Joseph Extended transdermal contraceptive regimens
BR0309032A (pt) * 2002-04-03 2005-02-01 Barr Lab Inc Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores
JP2006525358A (ja) 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
US20040251301A1 (en) 2003-05-05 2004-12-16 Niemann Amy C. Device for calculating anticipated days for menstruation
US20040222123A1 (en) 2003-05-06 2004-11-11 Barr Laboratories, Inc. Kit for pharmaceuticals
NZ585546A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
ATE474795T1 (de) 2003-09-04 2010-08-15 Pharmadesign Inc Behälter mit tablettenaufnahmehülsen zur lagerung und ausgabe von tabletten
JP2007507534A (ja) 2003-10-01 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 持続的三相避妊方法
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
MX2007004120A (es) * 2004-10-07 2007-06-15 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
CA2640432A1 (en) * 2006-01-27 2007-08-09 Duramed Pharmaceuticals, Inc. Regimens for treatment of conditions related to estrogen deficiency

Also Published As

Publication number Publication date
EP1453521B1 (en) 2013-09-04
BRPI0214716B8 (pt) 2021-05-25
JP2010180236A (ja) 2010-08-19
HUP0402651A2 (hu) 2005-04-28
HU230759B1 (hu) 2018-03-28
WO2003049744A1 (en) 2003-06-19
MXPA04005445A (es) 2005-03-23
DK1453521T3 (da) 2013-10-07
HK1076716A1 (zh) 2006-01-27
EP2305230A1 (en) 2011-04-06
BR0214716A (pt) 2004-12-14
JP2012107052A (ja) 2012-06-07
FR15C0050I2 (fr) 2018-05-11
NZ555299A (en) 2008-10-31
ES2428118T3 (es) 2013-11-06
NZ591627A (en) 2012-09-28
LU93156I2 (fr) 2016-09-20
PT1453521E (pt) 2013-10-08
US8680084B2 (en) 2014-03-25
IL207561A0 (en) 2011-07-31
CN1599614A (zh) 2005-03-23
AU2008237614B2 (en) 2011-04-21
RU2004121155A (ru) 2005-05-27
FR15C0050I1 (fr) 2015-08-28
BRPI0214716B1 (pt) 2018-10-02
US7320969B2 (en) 2008-01-22
US20100298279A1 (en) 2010-11-25
CA2468748A1 (en) 2003-06-19
NZ533242A (en) 2007-11-30
US20030139381A1 (en) 2003-07-24
CA2655959A1 (en) 2003-06-19
NZ570295A (en) 2011-05-27
PL370135A1 (en) 2005-05-16
WO2003049744B1 (en) 2003-08-28
US7858605B2 (en) 2010-12-28
CN100581550C (zh) 2010-01-20
IL162182A (en) 2012-02-29
SI1453521T1 (sl) 2013-11-29
US20080132473A1 (en) 2008-06-05
AU2002348272A1 (en) 2003-06-23
CN101757628A (zh) 2010-06-30
RU2351339C2 (ru) 2009-04-10
EP2305229A1 (en) 2011-04-06
AU2008237614A1 (en) 2008-11-27
EP1453521A1 (en) 2004-09-08
CA2655959C (en) 2013-05-14
US20080064670A1 (en) 2008-03-13
EP2305230B1 (en) 2015-11-04
HUS1800033I1 (hu) 2018-08-28
HK1154485A1 (en) 2012-04-27
CA2468748C (en) 2010-01-26
PL213122B1 (pl) 2013-01-31
AU2002348272B2 (en) 2008-07-31
HUP0402651A3 (en) 2009-01-28
US7615545B2 (en) 2009-11-10
ES2561491T3 (es) 2016-02-26
US8338396B2 (en) 2012-12-25
ZA200404249B (en) 2005-08-31
BG108736A (bg) 2005-03-31
US20120322777A1 (en) 2012-12-20
JP2005516913A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
IL207561A0 (en) Kits containing oral contraceptives and methods utilizing the same
MXPA03008497A (es) Composiciones y kits para el cuidado oral.
AU2002355012A1 (en) Microcapsules and oral compositions containing the same
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
IL164021A0 (en) Antibodies and anti-pharmaceutical compositions containing the same
AU2002357119A8 (en) Mitocidal compositions and methods
AU2002327185A8 (en) Diagnostic methods and devices
PL365518A1 (en) Oral composition
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
PL366305A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
EP1434772A4 (en) CONNECTIONS AND METHODS
AU2002357748A8 (en) Osteopontin-related compositions and methods
GB0111218D0 (en) Assays methods and means
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
AU2002365354A1 (en) Case and case holder
GB0016943D0 (en) Drills and their manufacture
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
GB0405536D0 (en) Composition and media
GB0120009D0 (en) Cause and effect diagnosis
EP1367123A4 (en) NEUROTONIN AND ITS USE
IL146655A0 (en) The use of leptin in fertility
AU2002359869A8 (en) Pak5-related compositions and methods
GB0030726D0 (en) Assay methods and kits therefor
GB0005282D0 (en) Reaction methods and kits